click to return to AHSR homepage

AHSR 2008 Agenda at a Glance

Monday, October 20

Tuesday, October 21

Wednesday, October 22

 

8:00 - 9:00am

Registration
Ballroom Prefunction 1
Buffet Breakfast

8:00 am - 9:00 am

Registration
Ballroom Prefunction 1
Buffet Breakfast

Plenary: Federal funding priorities

9:00 - 10:30am

Sessions

9:00 - 10:30am

Sessions

10:30 - 10:45am

Break: coffee, tea

10:30 - 10:45am

Break: coffee, tea

10:45am - 12:15pm

Sessions

10:45am - 12:15pm

Sessions

Pre-conference activities

1:00 - 3:00pm

New Investigator Workshop

Grantsmanship for Established PIs

 

3:00 - 3:15pm

break

3:15 - 5:15pm

Methods Workshop: Accounting for
Pre-Treatment Differences – Casemix Adjustment

Understanding, Accessing and Using SAMHSA Data Sets: Opportunities for Research

 

6:00 - 8:00pm

Skyline Ballroom
Welcoming reception
Travel awards presentation

12:30 - 2:00pm

Grand Ballroom 1, 2nd floor
Luncheon
Plenary: Emerging Research Areas in Behavioral Health Services

2:00 - 3:30pm

Sessions

3:45 - 5:15pm

Grand Ballroom C
Poster sessions
Reception

5:30pm

Closing
No planned activity for dinner or later

12:30 - 2:00pm

Grand Ballroom 1, 2nd floor
Luncheon
Plenary speaker: Stuart Altman

2:00

Closing

AHSR 2008 Breakout Session Schedule of Presentations

Monday, October 20, 12:00noon - 8:00pm

Registration

Monday, October 20, 1:00pm - 3:00pm

Pre-conference Activities

New Investigator Workshop

Meenaxi Hiremath, Dionne Jones, Redonna Chandler – National Institute on Drug Abuse
Bob Huebner – National Institute on Alcohol Abuse and Alcoholism
James Sorensen – University of California, San Francisco

Staff from NIDA’s Services Research Branch and NIAAA’s Division of Treatment and Recovery Research will conduct a grantsmanship workshop for new investigators. This workshop is intended to provide an overview of strategies for developing a successful research grant application for submission to NIDA and NIAAA. Topics to be covered include: Career Development, Grant Mechanisms, Essential Elements of the Grant Application, Grant Writing Tips, Common Pitfalls to Avoid, Human Subjects, IRBs, and Data Safety Monitoring Issues, The Review Process, and The Grant Decision-Making Process. The workshop is appropriate for junior investigators interested in pursuing a career in drug and alcohol abuse research. In addition, participants will have the opportunity to receive feedback from NIDA and NIAAA staff on concept papers.

Grantsmanship for Established PIs: Everything you ever wanted to know about NIH, but never asked

Thomas F. Hilton – National Institute on Drug Abuse

This workshop is limited to researchers who have served in the role of PI of an R01 grant for at least two years. It is intended to refine PIs’ knowledge about NIH business practices to enable more thoughtful strategic planning for new project initiatives that will sustain a long-range program of research and leadership of the field. Attendees may ahead of time submit anonymously all the questions they have been saving up over the years, which will be answered in the didactic portion of the program. Topics that will be addressed include: demystifying multiple-PI applications, cooperatives, centers, STTR/SBIR, and international projects. Emerging pending changes in NIH review procedures and project support levels will be discussed. There will also be a lively philosophical group discussion regarding what it takes to become and remain competitive

Methods Workshop
Accounting for Pre-Treatment Differences: Techniques of Casemix Adjustment

Daniel McCaffery, Beth Ann Griffin – RAND

3:00 – 4:00 pm (Part 1)   •   4:00 – 5:00 pm (Part 2)

Part 1: This workshop will introduce the need to more validly account for uncontrollable pre-treatment differences when patients or patient groups are to be compared. After a review of problems in the published literature, Dr. McCaffery will introduce attendees to methods for accounting for pre-treatment differences in risk and protective factors and adjusting for moderators due to intermittent institutionalization or imprisonment. Included will be a discussion of balancing adjustment approaches with power. The workshop will focus on propensity score approaches to estimating causal effects with observational data (what to do when everything but the kitchen sink may affect outcomes). Dr. McCaffery will show how to weight propensity scores to estimate average treatment effects on the treated population (estimating effectiveness for the target treatment population vs. all patients).

Part 2: This presentation will be followed by approximately 60 minutes hands-on familiarization with “twang,” a program for making casemix adjustments to research data. Freeware and dummy data will be provided. Part 2 attendees must bring a Windows-based laptop and power cord.

Understanding, Accessing and Using SAMHSA Data Sets: Opportunities for Research

Peter J. Delany – Substance Abuse and Mental Health Services Administration

This special workshop will orient participants to the numerous data sets available from the Substance Abuse and Mental Services Administration (http://www.oas.samhsa.gov). Attendees will learn about on-line analytic services and reports as well as how to access data and utilize for research.

Monday, October 20, 6:00pm - 8:00pm

Welcome Reception - Skyline Ballroom

• Welcome Remarks
• Travel Awards Presentations - NIDA and NIAA

Tuesday, October 21, 7:30am - 5:30pm

Registration

Tuesday, October 21, 8:00am - 9:00am

Buffet Breakfast - Skyline Ballroom

Concurrent Oral Presentations

Tuesday, October 21, 9:00am-10:30am

Olympia

Session 1:

Substance Abuse Treatment for Offender Populations

Moderator: Gary A. Zarkin, RTI International

A simulation of the lifetime benefits and costs of prison-based substance abuse treatment: Preliminary results

  • Gary A. Zarkin, RTI International

    Understanding how client health needs affect participation in services: Pathways to care

  • Getting offenders in treatment: Pathways and issues

    Faye Taxman, Cynthia Lum - George Mason University

    Co-morbid substance abuse and mental health in an offender population

  • Co-morbid substance abuse and mental health in an offender population

    Steven Belenko, Kimberly Houser - Temple University

    Results from the multi-site evaluation of the Serious and Violent Offender Re-entry Initiative program

  • Results from the multi-site evaluation of the Serious and Violent Offender Re-entry Initiative program

    Pamela K. Lattimore, Alexander Howell - RTI International

Michelangelo A

Session 2:

Role of the Workplace in Substance Abuse, Prevention and Treatment

Moderator: Elizabeth L. Merrick, Brandeis University

Discussant: Paul Roman, University of Georgia

  • Job stress, self-control, and addiction

    Jody Sindelar, Jason Fletcher, Bill Gallo - Yale University

  • Linking workplace policies and programs with substance abuse treatment utilization

    Bernard McCann - Brandeis University; Vanessa Azzone - Harvard Medical School; Deirdre Hiatt - MHN; Elizabeth Merrick, Dominic Hodgkin, Constance Horgan, Sharon Reif - Brandeis University

  • Cost savings of a brief intervention for drinking in an EAP

    Karen Chan Osilla, Erin Dela Cruz - RAND Corporation

  • Evaluating customer satisfaction in EAPs utilizing a 3rd party evaluator

    Dale Masi, MASI Research Consultants

Queen Mary

Session 3:

Medications for Substance Use Disorders

Moderator: Sharon Reif, Brandeis University

  • Utilization and persistence with alcohol dependence pharmacotherapies in a large commercial insurance population

    Hyong Un, Aetna Insurance Company

  • Persistence with oral naltrexone for alcohol treatment: Implications for healthcare utilization

    David R. Gastfriend, Alkermes, Inc.; Judith J. Stephenson - HealthCore, Inc.; Leslie Montejano, Shaohung Wang - Thomson Healthcare; Henry R. Kranzler - University of Connecticut School of Medicine

  • Medicaid and public funding for buprenorphine treatment of opioid dependence

    David Fiellin - Yale School of Medicine; Joseph Merrill, Beryl Schulman - University of Washington; Susan Busch, William Becker - Yale School of Medicine; Ruth Finkelstein - Academy of Medicine, NY

  • Use of buprenorphine for opioid dependence among the privately insured

    Colleen L. Barry, Yale School of Medicine; David Fiellin, Susan H. Busch - Yale School of Medicine

  • Early adoption and implementation of Vivitrol: Findings from the private addiction treatment sector

    Amanda J. Abraham, University of Georgia

Michelangelo B

Session 4:

HIV and HCV Risks and Risk Reduction

Moderator: Dionne Jones - National Institute on Drug Abuse

  • Unhealthy behaviors before and after HCV seroconversion among young injection drug users in San Francisco

    Judith Tsui, - Boston Medical Center; Eric Vittinghoff, Jennifer Evans, Judith Hahn, Kimberly Page-Shafer - University of California, San Francisco

  • Crack cocaine use and HIV risk behaviors among low income drug users and MSM: The role of services in the reduction of HIV incidence

    Martin Iguchi, Sandra Berry, Allison Ober - RAND Corporation

  • HIV/AIDS risk reduction health service utilization among injection drug using women

    Therese Fitzgerald, Boston University School of Social Work

  • Criminal correlates of HIV and HCV: Results from a randomized study of re-entering offenders

    Anne Rhodes - Virginia Commonwealth University; Faye Taxman - George Mason University

  • Understanding the role of peer workers in promoting health and social service linkages among underserved African-American women at high risk

    Hilary L. Surratt, James A. Inciardi - University of Delaware; Richard C. Rapp - Wright State University

• • • • •

Tuesday, October 21, 10:45am-12:15pm

Michelangelo A

Session 5:

Enhancing Practice Improvement in Community-Based Care for the Treatment of Drug Abuse

Moderator: Redonna Chandler, National Institute on Drug Abuse

Discussants: Lawrence Brown, Div. of Medical Services, Research and Information Technology and James May, Richmond Behavioral Health Authority

  • Enhancing substance abuse treatment and HIV prevention for women offenders

    Kimberly Bond, Alison Ordille - Mental Health Systems, Inc.;
    Nena Messina, Stacy Calhoun - UCLA Integrated Substance Abuse Program

  • Developing a CQI intervention to improve mental health services in a community based organization

    Debra Pantin - Palladia, Inc.;
    Charles Neighbors - The National Center on Addiction and Substance Abuse (CASA), Columbia University

  • Patient satisfaction with telemedicine-based evaluation in an addiction program

    R. Thomas Mathew, Kenny House, Michael Younkins - Coastal Horizons Center; Ashwin Patkar - Duke University; Robert Hubbard - NDRI

  • Technology transfer - Promoting change in the therapeutic community

    Britta Muehlbach, Erin Palmer - Daytop Village, Inc.; Keith Morgen - Monmouth University; Harry Zerler - Metromint Consultants

Olympia

Session 6:

Improving Treatment for Criminal Justice Populations

Moderator: Linda Frisman - Connecticut Department of Mental Health and Addiction Services

  • Under-serving the un-drug in criminal justice populations

    Patrick M. Flynn, Kevin Knight, George W. Joe, Janis T. Morey - Texas Christian University; Peter J. Delany - Substance Abuse and Mental Health Services Administration/Office of Applied Studies; Bennett W. Fletcher – National Institute on Drug Abuse; Peter D. Friedmann - Brown University; Carl G. Leukefeld - University of Kentucky; Michael L. Prendergas - University of California, Los Angeles; Joseph J. Shields - Catholic University of America and National Institute on Alcohol Abuse and Alcoholism

  • Parole officer background, role orientation and attitudes toward addiction and addiction treatment

    Aaron Johnson, Amanda Abraham - University of Georgia;
    Neil Kaltenecker, Marta Daniell - Georgia State Board of Pardons and Paroles

  • Treating methamphetamine dependent women offenders in prison

    Grace A. Rowan-Szal, George W. Joe, Jack Greener, Dwight D. Simpson - Texas Christian University; Jerry Vance - Indiana Department of Correction

  • The Step’n Out Study of collaborative behavioral management for drug-involved parolees

    Peter D. Friedmann - Brown University and Rhode Island Hospital; Faye S. Taxman - George Mason University; Anne G. Rhodes - Virginia Commonwealth University; Daniel J O’Connell - University of Delaware; Linda Frisman - Connecticut Department of Mental Health and Addiction Services; William M. Burdon - UCLA Integrated Substance Abuse Programs; Elizabeth C. Katz - Friends Research Institute; Mark Litt - University of Connecticut; Steven S. Martin - University of Delaware.

  • Show-rates and treatment continuation in California’s “Prop 36” diversion program: Are process improvement methods the solution?

    Darren Urada, Beth Rutkowski - University of California, Los Angeles

Michelangelo B

Session 7:

Organizational Practices to Enhance Substance Abuse Treatment

Moderator: Jack Stein - Center for Substance Abuse Treatment, Substance Abuse and Mental Health Services Administration

  • A peek inside the box: How information flows through drug treatment agencies

    Jay Ford - University of Wisconsin, Madison; Jennifer Wisdom - Columbia University; Meg Wise - University of Wisconsin, Madison

  • An organizational intervention to address nicotine dependence in drug treatment settings

    Joseph Guydish - University of California, San Francisco; Douglas Ziedonis - University of Massachusetts Medical School; Barbara Tajima, Mable Chan - University of California, San Francisco; Greg Brigham - Maryhaven, Inc.

  • Private health plans’ management of substance abuse treatment: The treatment entry process

    Elizabeth L. Merrick, Constance M. Horgan, Deborah W. Garnick, Sharon Reif, Maureen T. Stewart - Brandeis University

  • Program characteristics and patterns of delivery of core and comprehensive services in outpatient non-methadone substance abuse treatment programs

    Jennifer R. Edwards, Danica Knight, Kirk Broome, Patrick Flynn - Texas Christian University

  • Organizational quality of drug abuse clinics and client satisfaction:

    Robert L. Stout, Karen B. Friend, William H. Zywiak - Decision Sciences Institute/PIRE; Pamela Block, SUNY Stony Brook; Amy Lagasse, Constance Lawson, Ruth Shipton-Levy - Decision Sciences Institute/PIRE

queen mary

Session 8:

Treating Medical and Mental Health Conditions Among Substance Abusers

Moderator: Mark Willenbring - National Institute on Alcohol Abuse and Alcoholism

  • Longitudinal relationships between polysubstance use and psychological distress in rural stimulant users:
    Results from a three-state natural history study

    Brenda M. Booth, Geoffrey M Curran, X Han, S Frith - University of Arkansas for Medical Sciences; Carl Leukefeld - University of Kentucky; Jichuan Wang, Russel Falck,Robert G. Carlson - Wright State University.

  • Unhealthy drinking and preventive medical service use among older adults

    Elizabeth L. Merrick, Dominic Hodgkin, Deborah W. Garnick, Constance M. Horgan, Lee Panas, Marian Ryan, - Brandeis University; Richard Saitz - Boston Medical Center and Boston University School of Medicine; Frederic C. Blow, University of Michigan and Department of Veterans Affairs

  • The quality of asthma care in adult Medicaid patients with substance related disorders

    Jeffrey D. Baxter, Mihail Samnaliev, Robin E. Clark - University of Massachusetts Medical School

  • Medical expenditures for Medicaid beneficiaries with psychiatric and substance use disorders

    Robin Clark, Mihail Samnaliev - University of Massachusetts Medical School

• • • • •

Tuesday, October 21, 12:30pm - 2:00pm

grand ballroom 1

Buffet Luncheon and Plenary:
A Broader View: Innovation in Delivery of Behavioral Health Service

  • David Chambers, D.Phil., Chief, Services Research and Clinical Epidemiology Branch, Division of Services and Intervention Research National Institute of Mental Health

  • Wilson M. Compton, M.D., M.P.E., Director, Division of Epidemiology, Services and Prevention Research, National Institute on Drug Abuse

  • Mark L. Willenbring, M.D., Director, Division of Treatment and Recovery Research, National Institute on Alcohol Abuse and Alcoholism

  • Chair: Constance Horgan, Brandeis University

• • • • •

Tuesday, October 21, 2:00pm - 3:30pm

Michelangelo A

Session 9:

New Components for Alcohol Treatments: Clinical and Cost Impacts

Moderator: Robert L. Stout - Decision Sciences Institute

  • Effects of case monitoring on health care utilization over three years

    Robert L. Stout - Decision Sciences Institute; Donald Shepard - Brandeis University;

  • Effectiveness of extended telephone continuing care

    James R. McKay, M. Long, Kevin G. Lynch, Deborah Van Horn, David Oslin - University of Pennsylvania School of Medicine and Philadelphia Veterans Affairs Medical Center

  • Cost-benefit analysis of telerecovery and other approaches to continuing care prevention for
    cocaine or alcohol dependent clients

    Donald S. Shepard - Brandeis University; James McKay - University of Pennsylvania; Matthew Neuman - Brandeis University; Aaron Beaston-Blaakman - Consultant

  • Cost and cost-effectiveness of the COMBINE study for alcohol dependent patients

    Jeremy Bray, Gary A. Zarkin, Jeremy W. Bray, Arnie Aldridge, Debanjali Mitra - RTI International; David J. Couper - University of North Carolina; Ron A Cisler - University of Wisconsin

Olympia

Session 10:

Ensuring Quality Substance Abuse Treatment for Women: Special, Tailored or Matched Services

Moderator: Constance Weisner - Kaiser Permanente and University of California, San Francisco

  • The Women's Recovery Group Study: A stage I trial of women-focused group therapy for substance use disorders vs. mixed-gender group drug counseling

    Shelly Greenfield, Harvard Medical School

  • Tailoring treatment to women in outpatient substance abuse treatment 1995-2005

    Cynthia Campbell - Kaiser Permanente; Rebecca Wells - School of Public Health, University of North Carolina; Jeffrey A. Alexander - University of Michigan, School of Public Health; Christy Harris Lemak - College of Public Health and Health Professions, University of Florida

  • Addiction health services for women: Effects of changing social policies on service delivery systems

    Christine Grella, University of California, Los Angeles

  • Gender differences in need-service matching in comprehensive substance abuse treatment

    Jeanne C. Marsh, Hee-Choon Shin, Christina Andrews - University of Chicago

queen mary

Session 11:

Applying Research on Substance Abuse Performance Measures to Quality Management

Moderator: Deborah Garnick, Brandeis University

  • Ongoing development of substance abuse performance measures by the Washington Circle for monitoring publicly-funded treatment services

    Margaret Lee, Andrea Acevedo, Deborah W. Garnick, Constance M. Horgan - Brandeis University; Washington Circle Public Sector Workgroup

  • Improving quality through engagement: An ethnographic exploration of engaging consumers in
    substance abuse treatment

    Stuart Henderson, Sarah Carnochan - University of California, San Francisco

  • WC’s continuity of care performance indicator: Relationship with adolescent substance abuse recovery status and the impact of assertive continuing care

    Bryan R. Garner, Mark D. Godley, Rodney R. Funk - Chestnut Health Systems; Margaret T. Lee, Deborah W. Garnick - Brandeis University

  • Developing a new measure of outpatient addiction treatment quality for the VA

    Alex H.S. Harris, Keith Humphreys - VA Palo Alto Health Care System and Stanford University School of Medicine; Dan Kivlahan - VA Puget Sound Health Care System; Thomas Bowe, Jenny Hyun, John W. Finney - VA Palo Alto Health Care System and Stanford University School of Medicine.

  • Applying performance monitoring and quality improvement to medical practice

    Mark Willenbring - National Institute on Alcohol Abuse and Alcoholism

Michelangelo B

Session 12:

Developing a Skilled Practitioner Workforce Using Lower-Cost Training Interventions

Moderator: Cecelia McNamara Spitznas, National Institute on Drug Abuse

Discussant: Barbara Kistenmacher, Bronx Lebanon Hospital Center

  • Rationale and design of a randomized trial to disseminate cognitive-behavioral therapy to practitioners

    Mary Jo Larson - Brandeis University; Maryann Amodeo - Boston University School of Social Work; Susan Storti - Brown University Medical School; Joseph LoCastro - Boston University School of Medicine and Veterans Affairs Boston Healthcare System; Jordana Muroff - Boston University School of Social Work

  • Can individualized web-based training transfer to practitioners the necessary knowledge and attitudes for CBT adoption?

    Eric Gerstenberger - New England Research Institutes; Maryann Amodeo, Jordana Muroff - Boston University, School of Social Work; Joseph LoCastro - Boston University School of Medicine and Veterans Affairs Boston Healthcare System; Mary Jo Larson - Brandeis University

  • Exposure to web-based and manual training and clinical utilization of CBT skills in community addiction treatment programs

    Joseph LoCastro - Boston University School of Medicine; Jordana Muroff - Boston University, School of Social Work; Eric Gerstenberger, Lauren Smith - New England Research Institutes; Mary Jo Larson - Brandeis UniversityJoseph LoCastro, Boston University School of Medicine

  • Does supervisor engagement promote practitioner transfer of knowledge into practice?

    Maryann Amodeo, Jordana Muroff - Boston University School of Social Work; Mary Jo Larson - Brandeis University

• • • • •

Poster Session

Grand Ballroom 1

Tuesday, October 21, 3:45pm - 5:15pm

1 Patterns of drug treatment entry by Latino male injection drug users from different national/geographical backgrounds Humberto Reynoso-Vallejo - Boston University School of Social Work; Deborah Chassler, Julie Witas, Lena Lundgren - Boston University School of Social Work
2 Puerto Rican injection drug users: Prevention implications in Massachusetts and Puerto Rico Luz Marilis López - Boston University School of Social Work; Lisa de Saxe Zerden, Therese C. Fitzgerald, Lena M. Lundgren - Boston University School of Social Work
3 Client retention in residential drug treatment for Latinos Maryann Amodeo - Deborah Chassler, Catherine Oettinger - Boston University School of Social Work; Wilfred Labiosa - Casa Esperanza, Inc.; Lena Lundgren - Boston University School of Social Work
4 Implications of Medicaid coverage in a program for Latino substance users Sara S. Bachman, Angela W. Walter - Boston University School of Social Work; Nellie Kuilan - Tapestry Health / La Voz; Lena M. Lundgren - Boston University School of Social Work
5 Implementation lessons learned: Experience of the Pennsylvania SBIRT project Janice Pringle, Cynthia Holland - University of Pittsburgh, School of Pharmacy
6 Evaluation of telephone-based screenings for alcohol and other drug problems Mary Brolin - Brandeis University; Amy Rubin - Boston University; Daniel Alford, Christopher W. Shanahan, Theresa Kim, Lee Ellenberg, Indira Persand, Alissa Almeida - Boston Medical Center; Jennifer Perloff - Brandeis University; Karen Pressman, Carol Girard - Bureau of Substance Abuse Services, Massachusetts Department of Public Health
7 Evaluation of telephonic alcohol screening and brief intervention (SBI) for at risk drinking in an employee assistance program (EAP) Tracy L. McPherson - George Washington University Medical Center; Dennis Derr, Judy Mickenberg - Aetna Behavioral Health; Eric Goplerud - George Washington University Medical Center; Laura Chaney - Aetna Behavioral Health
9 SBIRT patient outcomes in a hospital-district program Thomas Bohman, Richard Spence - University of Texas at Austin; Vicki Waters - Baylor College of Medicine; Mary Marden Velasquez, Kirk Von Sternberg, Lynn Wallisch, Albert Yeung, Mary S. Cook - University of Texas, Austin
9 Evidence-based practice attitudes and leadership: Implications for developing dual diagnosis capability Ron Claus, Andrew L. Homer - Missouri Institute of Mental Health, University of Missouri-Columbia; Heather Gotham - Mid-America Addiction Technology Transfer Center, University of Missouri-Kansas City
10 The Connecticut Co-Occurring Practice Improvement Collaborative: Implementing quality using the DDCAT Index Julienne Giard, Fred Morton - Connecticut Department of Mental Health & Addiction Services; Mark P. McGovern - Dartmouth Medical School
11 DDCAT fidelity and co-occurring service delivery Jessica Brown, Joseph Comaty - Louisiana Department of Health & Hospitals
12 Using administrative data to assess the long term impact and differential effectiveness of therapeutic community substance abuse treatment on relapse to alcohol and drug use, criminal recidivism, and quality of life Deena Murphy, Robert Hubbard - National Development and Research Institutes, Inc (NDRI); Karen Kelley, Benjamin Burnette, Aubrey Daquiz - Triangle Residential Options for Substance Abusers (TROSA)
13 What organizational characteristics facilitate using evaluation for organizational learning in North Carolina’s nonprofit sector? Deena M. Murphy - National Development and Research Institutes, Inc. (NDRI)
14 The role of organizational commitment in practitioner's implementation of evidence-based practices in substance abuse treatment settings Irene Manfredo - State University of New York at Albany
15 Organizational factors influencing practice improvement in community-based care Alison Breland - Richmond Behavioral Health Authority; J. Randy Koch - Virginia Commonwealth University; James May, Dawn Farrell-Moore - Richmond Behavioral Health Authority; Dace Svikis - Virginia Commonwealth University; Faye Taxman - George Mason University
16 Organizational culture and climate as influences on practice in substance abuse treatment Brenda D. Smith - State University of New York at Albany
17 Correlates of core and comprehensive service provision in outpatient non-methadone substance abuse treatment settings Danica K. Knight, Jennifer Edwards, Kirk Broome, Patrick Flynn - Texas Christian University
18 Organizational predictors of treatment participation in outpatient drug abuse programs Kirk Broome, Jennifer Edwards, Danica K. Knight, Patrick Flynn - Texas Christian University
19 Organizational characteristics associated with the provision of health screening services in substance abuse treatment setting in the US Lynn Warner - State University of New York at Albany
20 Impact of implementing an electronic clinical record on the organization culture and quality of care Minakshi Tikoo - University of Connecticut Health Center
21 An operations management assessment of process/quality improvement in a major U.S. hospital addictions outpatient setting Michael Richards, William Rafelson, Emara Nabi, Aaron Kingson, Mai Nguyen - Brandeis University
22 Clinical practice guidelines as an indicator of quality: The case of the smoking cessation guideline Hannah K. Knudsen - University of Kentucky
23 The advancing recovery model: Promoting quality through systems change Laura Schmidt - University of California, San Francisco; Traci Rieckmann - Oregon Health & Science University; Dace Svikis - Virginia Commonwealth University; Paul Roman - University of Georgia; Victor Capoccia - Open Society Institute; Dennis McCarty - Oregon Health & Science University
24What components of a continuing care model relate to quality chemical dependency treatment over 5 years? Cynthia I. Campbell, Felicia Chi, Stacy Sterling - Kaiser Permanente; Constance Weisner - Kaiser Permanente and University of California, San Francisco
25 Substance abuse treatment consumers’ perspectives on quality Sarah Carnochan; Stuart Henderson - University of California, San Francisco
26 Patient satisfaction and retention in methadone-maintenance treatment Sharon M. Kelly, Robert P. Schwartz - Friends Research Institute; Kevin E. O’Grady - University of Maryland, College Park; Barry S. Brown - Friends Research Institute and University of North Carolina, Wilmington
27 Testing the feasibility of an evidence-based substance abuse preventive intervention for youth with psychiatric disorders J. Randy Koch - Virginia Commonwealth University; Peggy S. Meszaros - Virginia Tech; Brian L. Meyer, Dawn Fitzelle, Virginia Commonwealth University; Crystal Lane - Virginia Tech; James Pritchett - New River Valley Community Services Agency
28 Measuring the impact of system changes on youth outcomes: A working case study Carolyn Castro-Donlan - Massachusetts Department of Public Health; Craig Johnson, Annette Hanson, Thomas Innis - ProVentive, Inc.
29 The relationship between clinician recovery status and work attitudes in the substance abuse treatment field Sara L. Curtis, Lillian T. Eby, Carrie S. Hurst, Lisa Baranik, Carrie Owen - University of Georgia
30 The effect of religious institutions on drug abuse that lead to risky decisions associated with HIV/AIDS: A focus on the African American community Adrian Price - Kentucky State University
31 Redemption or rehabilitation: A comparative analysis of religion in faith-based and traditional secular substance abuse treatment Margot Trotter Davis - Brandeis University
32 Spirituality and recovery among clients in Missouri’s Access to Recovery program: A multidimensional assessment of spirituality and religious practice Jeffrey Noel, Andrew Homer, Helen Seo, Dong Cho - University of Missouri School of Medicine
33 Missouri’s Access to Recovery program: Client recovery at 6 and 12 month follow-up Jeffrey Noel, Andrew Homer, Helen Seo, Dong Cho - University of Missouri School of Medicine
34 Client and service characteristics associated with successful completion of the Texas Access to Recovery program Laurel Mangrum - University of Texas; Karen Eells – Texas Department of State Health Services
35 Extended-release Naltrexone injectable suspension for treatment of alcohol dependence in urban primary care Joshua Lee - New York University
36 The effects of extended-release naltrexone on holiday drinking in alcohol dependent patients Robert Forman - Alkermes, Inc.; Sandra Lapham - Behavioral Health Research Center of the Southwest; Mark Alexander, Ari Illeperuma - Alkermes, Inc.; Michael J Bohn - Aurora Psychiatric Hospital
37 Medication treatment of alcohol use disorders in the Veterans Health Administration Alex H.S. Harris, Thomas Bowe, Keith Humphreys - VA Palo Alto Health Care System and Stanford University School of Medicine
38 Cost-effectiveness of buprenorphine and naltrexone for opioid dependence in Malaysia Jennifer Ruger, Richard S. Schottenfeld, Marek C. Chawarski, Jody Sindelar - Yale School of Medicine
39 Employment assistance for California’s Proposition 36 drug offenders Elizabeth Evans, Darren Urada - UCLA, Integrated Substance Abuse Programs, Semel Institute for Neuroscience and Human Behavior
40 Getting offenders in treatment: Pathways and issues Adria Trotman, Faye S. Taxman - George Mason University; Monique Wilson - Friends Research Institute
41 Case managers’ service orientation and youth outcomes in the juvenile justice system Douglas W. Young, Jill L. Farrell - University of Maryland; Faye S. Taxman - George Mason University
42 Treatment engagement and time to recidivism for young African-American and Latino male offenders Robert Dunigan - Brandeis University
43 The effectiveness of a brief HIV/ HCV intervention in reentry: Race and gender differences James A. Inciardi, Steven S. Martin, Daniel J. O'Connell, Hilary L. Surratt - University of Delaware
44 Institutional arrangements and adoption of culturally competent practices in outpatient substance abuse treatment Erick Guerrero, Jeanne Marsh - University of Chicago
45 Moderating effects of family cohesion on perceived racial discrimination and substance use disorders and lifetime suicidal ideation among Asian Americans nationwide Hyeouk Chris Hahm - Boston University, School of Social Work; In Han Song - Adelphi University, School of Social Work
46 The relationship between family support, persistent feelings of self-worth and HIV-related thinking myths in a sample of female drug users Jamieson Duvall, Carrie Oser, Jennifer Mooney, Michele Staton-Tindall, Carl Leukefeld - University of Kentucky
47 Abstinence outcomes among inpatient/ residential patients with substance use disorders: Investigating predictors across the continuum of care Jeanne A. Schaefe, Ruth C. Cronkite; Patricia Turrubiartes; Kirsten Unger-Hu - VA Palo Alto Health Care System
48 Risky sex and stimulant use in rural America: An indicator of poor health system performance? Ty Borders, Brenda Booth, Trish Wright, Katharine Stewart - University of Arkansas for Medical Sciences; Russel Falck, Robert Carlson, Jichuan Wang - Wright State University; Carl Leukefeld - University of Kentucky
49 Rural residence, race, and reports of barriers to alcohol treatment: Findings from the NESARC Ty Borders - University of Arkansas for Medical Sciences
50 New York’s drug, welfare, and criminal justice policies: The experience of African American women in distressed households Liliane C. Windsor - Rutgers, School of Social Work; Eloise Dunlap - National Development & Research Institutes
51 Disparities in substance abuse treatment utilization among female Medicaid beneficiaries with and without mental retardation Elspeth Slayter - Salem State College
52 Self-reported inpatient utilization among patients undergoing treatment for substance use: Are there differences by sexual orientation? Donald Allensworth-Davies, Boston University School of Public Health, Jeffrey H. Samet, Debbie M. Cheng - Boston University Schools of Medicine and Public Health; Anna Fitzgerald, Theresa W. Kim - Boston University School of Medicine; Richard Saitz - Boston University Schools of Medicine and Public Health
53 Substance abuse treatment for homeless individuals: Examining treatment outcomes and characteristics associated with success Nicola A. Conners-Burrow, Latunja R. Sockwell, Isis D. Martel - University of Arkansas for Medical Sciences
54 Maintaining quality in cultural adaptation of evidence-based substance abuse prevention curricula: Systematic procedures to help host agencies adapt with fidelity Lori K. Holleran Steiker - University of Texas at Austin School of Social Work; Laura M. Hopson - University of Albany School of Social Work
55 Assessing predictors of treatment retention in a community outpatient substance abuse clinic Ryan Vandrey, Maxine Stitzer, Jeannie Fry - Johns Hopkins University School of Medicine; Patricia Stabile - Harbel Prevention and Recovery Center
56 The first call – What awaits clients when they call seeking treatment? Anna Wheelock, Jay Ford, Andy Quanbeck, Alice Pulvermacher - University of on Wisconsin, Madis
57 Latent class analysis of substance use disorders in a diverse welfare-to-work sample Sharon C. Sung, Bruce Schwartz, Scott Wetzler, Arthur Swanson - Montefiore Medical Center and Albert Einstein College of Medicine
58 Treatment-fit: A novel response to client dropout Justin Pulford, Peter Adams, Janie Sheridan - University of Auckland, New Zealand
59 Project SPREAD: Survey of practical research methods to aid in dissemination Jennifer E. Hettema, James L. Sorensen, Adrienne O. Wente - University of California, San Francisco

• • • • •

Wednesday, October 22, 7:30am - 11:00pm

Registration

Wednesday, October 22, 8:00am - 9:00am

Grand ballroom 1

Buffet Breakfast and Plenary: Federal Funding Priorities

• Redonna Chandler, National Institute on Drug Abuse
• Cherry Lowman, National Institute on Alcohol Abuse and Alcoholism
• Jack Stein, Center for Substance Abuse Treatment
• Chair: James Sorensen, University of California, San Francisco

• • • • •

Wednesday, October 22, 9:00am-10:30am

Michelangelo A

Session 13:

Incarceration and Opioid Dependence: Impact, Interventions, and Implications

Moderator: Robert P. Schwartz, Friends Research Institute

  • Incarceration and opioid withdrawal: The experiences of methadone patients and out-of-treatment heroin users

    Shannon Gwin Mitchell, Sharon M. Kelly - Friends Research Institute; Barry S. Brown - Friends Research Institute and University of North Carolina; Heather S. Reisinger Friends Research Institute and Iowa City VA Medical Center; James A. Peterson - Friends Research Institute; Michael Agar - Friends Research Institute and Ethknoworks, Robert P. Schwartz - Friends Research Institute

  • Frequency and severity of arrest charges: Impact of interim methadone treatment

    Robert P. Schwartz, Jerome H. Jaffe, Sharon Kelly - Friends Research Institute; Ahmed A Ashraf - Morgan State University; Kevin E O’Grady - University of Maryland, College Park

  • Supportive reentry: Who seeks linkage to community methadone treatment upon release from incarceration?

    Michelle McKenzie, Amy Nunn, Ank Nijhawan, Portia Thurmond, Nick Zaller, Josiah D. Rich - The Miriam Hospital/Brown University Warren Alpert Medical School

  • A randomized clinical trial of methadone maintenance for prisoners: Findings at 12-months post release

    Michael Gordon, Timothy W. Kinlock, Robert P. Schwartz - Friends Research Institute

Olympia

Session 14:

Reducing Health Disparities: Differences in Utilization

Moderator: Robert Huebner, National Institute on Alcohol Abuse and Alcoholism

Discussant: James L. Sorensen, University of California – San Francisco

  • Adolescent girls entering alcohol and drug treatment in managed care: Services utilization and extra-treatment factors and implications for outcomes

    Stacy Sterling, Felicia Chi, Cynthia Campbell - Kaiser Permanente

  • Service disparities among rural populations: Health, mental health, substance use, and service utilization among rural and urban incarcerated women

    Michele Staton-Tindall, Jamieson L. Duvall, Carl Leukefeld, Carrie B. Oser - University of Kentucky

  • Health services utilization among HIV and HCV seropositive female prisoners upon community reentry

    Carrie Oser, Jennifer Havens, Michele Staton-Tindall, Jennifer Mooney, Hannah Knudsen, Jamieson Duvall, Carl Leukefeld - University of Kentucky

  • Problem severity, service utilization, and treatment outcomes among Native American/Alaska Native and Asian American/Pacific Islander drug abusers

    Fei Wu, Yih-Ing Hser – University of California, Los Angeles

Michelangelo B

Session 15:

Economic Analyses of Substance Abuse Consequences and Treatments

Moderator: Sarah Q. Duffy, National Institute on Drug Abuse

  • Revisiting the cost-effectiveness of the COMBINE study: The patient perspective

    Laura J. Dunlap, Gary A. Zarkin, Jeremy W. Bray, Michael Mills - RTI International; Daniel R Kivlahan - University of Washington/Seattle Veterans Administration; James McKay - University of Pennsylvania; Patricia Latham - Medical University of South Carolina; J. Scott Tonigan - University of New Mexico

  • Costs of HIV prevention among out of treatment drug using women: Results of a randomized controlled trial

    Jennifer Prah Ruger - Yale School of Medicine; Arbi Ben Abdallah, Linda Cottler - Washington University School of Medicine

  • The economic cost of underage drinking in Florida

    Kathryn McCollister, Michael French, Ioana Popovici - University of Miami

  • Cost-effectiveness of computer-assisted delivery of cognitive-behavioral therapy for addiction

    Todd A. Olmstead - University of Connecticut Health Center; Cary D. Ostrow - Liberation Programs; Kathleen M. Carroll - Yale University School of Medicine

Queen Mary

Session 16:

Alcohol Screening and Health Promotion Activities

Moderator: Richard Saitz - Boston Medical Center and Boston University School of Medicine

  • Too busy or not interested? Heavy drinking and health promotion activities

    Susan Ettner - UCLA; Michael T. French - University of Miami; Johanna C. Maclean - Cornell University; Ioana Popovici, University of Miami

  • Using the AUDIT-C to screen for risk of alcohol dependence: A stratum-specific likelihood ratios analysis

    Anna DeBenedetti, CC Maynard, DR Kivlahan, KA Bradley - VA Puget Sound Health Care System and University of Washington

  • Alcohol screening and monitoring with the AUDIT-C: How stable are patients’ alcohol screening scores?

    Katharine A. Bradley, Gwen Greiner, EC Williams, DR Kivlahan -VA Puget Sound Health Care System

  • Use of an electronic clinical reminder for brief alcohol counseling is associated with resolution of alcohol misuse

    Emily C. Williams, Gwen Greiner, Carol E. Achtmeyer, Bryan Volpp, Dan Kivlahan, Katharine A. Bradley - VA Puget Sound Health Care System and University of Washington

  • Reduced days of heavy drinking after SBIRT: Analysis of outcome differences by problem severity and client characteristics

    Richard Spence; Tom Bohman, Vicki Waters, Mary Velasquez, Kirk Von Sternberg, Lynn Wallisch, Albert Yeung, Mary S. Cook - University of Texas, Austin

• • • • •

Wednesday, October 22, 10:45am - 12:15pm

Michelangelo A

Session 17:

Examining the Role of Medicaid in the Provision of Outpatient Substance Abuse Treatment Services

Moderator: Duane McBride, Andrews University

  • Substance abuse services in states with small and large African-American populations: The role of facilities' acceptance of Medicaid

    Mesfin Mulatu, The MayaTech Corporation

  • The role of Medicaid acceptance in moderating the relationship between program ownership and service provision in outpatient treatment programs in the US

    Duane McBride, Andrews University

  • State Medicaid and authorizing policies for ancillary, transitional assistance and service coordination linkages as correlates of outpatient treatment program service provision

    Jamie Chriqui - University of Illinois, Chicago; Yvonne M. Terry-McElrath - University of Michigan; Duane C. McBride - Andrews University; Mesfin Mulatu, Shelby Eidson - The MayaTech Corporation

  • What drives Medicaid payment acceptance at substance abuse treatment programs? Taking a look at state policy and program characteristics

    Yvonne Terry-McElrath, University of Michigan

Olympia

Session 18:

State Policies: Influencing Use and Treatment

Moderator: Michael Botticelli - Bureau of Substance Abuse Services, Massachusetts Department of Public Health

  • Influences of state policymaking and markets on substance abuse services

    Laura A Schmidt - University of California, San Francisco; Tammy Tam - Alcohol Research Group, Public Health Institute

  • State level treatment gap and other policies are associated with individual drug use

    May Yang - New England Research Institutes;
    Mary Jo Larson – Brandeis University; Anne Stoddard, New England Research Institutes

  • State purchasing levers to advance quality through promotion of evidence-based practices for alcohol and drug treatment

    Traci Rieckmann, Anne Kovas - Oregon Health & Sciences University;
    Elaine Cassidy – The Robert Wood Johnson Foundation; Dennis McCarty - Oregon Health & Science University

  • No news is bad news: Methamphetamine precursor laws and youth amphetamine-related outcomes

    Curtis J. VanderWaal - Andrews University; Yvonne M. Terry-McElrath - University of Michigan; Duane C. McBride - Andrews University; Jamie F. Chriqui - University of Illinois at Chicago

  • The role of the state authority in fidelity monitoring, outcomes measurement, and adoption of evidence-based practices

    Nicole Stettler, Traci Rieckmann - Oregon Health & Sciences University; Elaine Cassidy - The Robert Wood Johnson Foundation; Jacklyn Kohon - Oregon Health & Science University

Queen Mary

Session 19:

Improving the Quality of Addiction Care in General Medical Settings

Moderator: Jeffrey Samet, Boston University

  • Validity of single item screening tests for unhealthy alcohol and drug use

    Peter Smith - East Boston Neighborhood Health Center; Donald Allensworth-Davies, Richard Saitz - Boston Medical Center and Boston University School of Public Health

  • Alcohol counseling reflects higher quality of primary care

    Richard Saitz - Boston Medical Center and Boston University School of Medicine; Nicholas J. Horton - Smith College; Debbie M. Cheng, Jeffrey H. Samet - Boston University School of Medicine and Boston University School of Public Health

  • Is methadone maintenance treatment and indication missing from the medical record? A patient safety issue

    Richard Saitz - Boston Medical Center and Boston University School of Medicine; Nicholas J. Horton - Smith College; Debbie M. Cheng, Jeffrey H. Samet - Boston University School of Medicine and Boston University School of Public Health

  • Will patients initiate chronic disease management care for substance dependence?

    Theresa Kim, Richard Saitz - Boston University School of Medicine; Debbie.M. Cheng, Michael Winter - Boston University School of Public Health; Jeffrey H. Samet - Boston University School of Medicine

Michelangelo B

Session 20:

Substance Use and Its Effects Among Children and Adolescents

Richard Frank - Harvard Medical School

  • The effect of maternal depression and substance abuse on children’s cognitive, behavioral, and educational outcomes

    Richard Frank, Ellen Meara - Harvard Medical School

  • Childhood maltreatment and youth alcohol problems

    Sunny Hyucksun Shin - Boston University School of Social Work; Erika Edwards - Boston University Data Coordinating Center; Timothy Heeren - Boston University School of Public Health

  • The association of ecstasy use and academic achievement among adolescents in two U.S. national surveys

    Silvia S Martins, Pierre K. Alexandre - Johns Hopkins Bloomberg School of Medicine

  • Effective thresholds of adolescent self-help meeting attendance and their predictors

    Michael L. Dennis, Rod Funk, Susan H. Godley, Mark D. Godley, Lora Passetti - Chestnut Health Systems

  • Relationships between publicly funded adolescent drug treatment, criminal justice and mental health treatment

    Jennifer Wisdom, James Weaver, Martina Pavlicova - New York State Psychiatric Institute; Carla A. Green – Kaiser Permanente Center for Health Research; Dongseok Choi - Oregon Health & Science University

• • • • •

Wednesday, October 22, 12:30pm - 2:00pm

Grand ballroom 1

Buffet Luncheon and Plenary: Healthcare Reform Potential Impact of the 2008 Presidential Election

• Stuart Altman, Sol C. Chaikin Professor of National Health Policy, Heller School, Brandeis University
• Chair: Lisa Lynch, Dean, Heller School, Brandeis University

• • • • •

PRINTABLE AGENDA AT A GLANCE PDF

PRINTABLE SCHEDULE OF BREAKOUT SESSION PRESENTATIONS